Suchen Sie nach Informationen zu Actelion US-Hauptsitz? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.drugs.com/manufacturer/actelion-pharmaceuticals-us-inc-365.html
Actelion submits a New Drug Application to the FDA for macitentan (Opsumit) for the treatment of patients with pulmonary arterial hypertension - October 22, 2012; Drugs Associated with Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. manufactures, markets and/or distributes more than 6 drugs in the United States.
http://actelionpharmaceuticalsglobal.com/contact-us/
2555 West River Road North. Minneapolis, MN 55411. USA. PHONE NUMBER : +1 209-251-6537. EMAIL : [email protected].
https://www.dnb.com/business-directory/company-profiles.actelion_pharmaceuticals_us_inc.0874582b0ab278f5c571a35225a06614.html
Address: 1125 Bear Tavern Rd Titusville, NJ, 08560-1504 United States See other locations Phone: ? Website: www.janssen.com
https://en.wikipedia.org/wiki/Actelion
https://www.dnb.com/business-directory/company-profiles.actelion_us_holding_company.61fb448ba1d79c3bb425f19b1ce668d5.html
Address: 5000 Shoreline Ct Ste 200 South San Francisco, CA, 94080-1956 United States See other locations Phone: ? Website: www.janssen.com
http://actelionpharmaceuticalsglobal.com/about-us/
Actlion Pharmaceuticals has always been committed to ensuring that our valued customers are our priority. For years our key objective has always been to treat all our valued clients with a personal and professional touch that differentiates us in the healthcare wholesalers and Manufacturing, and we continue to maintain this culture throughout our organisation.
https://www.bloomberg.com/profile/company/0006166D:US
Company profile page for Actelion Pharmaceuticals US Inc including stock price, company news, press releases, executives, board members, and contact information
https://craft.co/actelion-pharmaceuticals
Healthcare biotech drug development pharma. Actelion Pharmaceuticals is a biopharmaceutical company focusing on the discovery, development, and commercialization of innovative treatments to serve high unmet medical needs. It is engaged in the development of tailored medicines to address pulmonary arterial hypertension (PAH).
https://www.swissbiotech.org/listing/actelion-pharmaceuticals-ltd/
Hengrui Europe Biosciences AG. Hengrui Europe Biosciences is a biotech start-up based in Zurich, Switzerland, established in 2021. We are a subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd. and are building a new research center with a differentiated technology platform to support innovative antibody discovery research. 8048 Zürich.
https://www.bloomberg.com/profile/company/ATLIF:US
Company profile page for Actelion Ltd including stock price, company news, press releases, executives, board members, and contact information
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Actelion US-Hauptsitz gefunden haben.
